The OvPlex Panel is an early detection test for ovarian cancer, developed by HealthLinx in collaboration with ARL Pathology.
The test works by measuring five different biomarkers (proteins) in blood that are associated with ovarian cancer. It then builds a diagnostic based on that information rather than relying on a single marker for the disease.
Results are available within a fortnight.
Online:
www.healthlinx.com.au
Phone: 03 9208 4200
Phone: 03 9208 4200
Related Products
Amsbio Acepix FFPE tissue blocks
Amsbio has expanded its range of high-quality formalin-fixed, paraffin-embedded (FFPE) tissues...
Promega Paradyme 27GY STR System
The Paradyme 27GY STR System features a novel enzyme that reduces the most common type of...
Mercodia Insulin MBeads Assay
The assay is designed to offer high accuracy by specifically measuring human insulin while...
